BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 18204047)

  • 1. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
    Rawal N; Rajagopalan R; Salvi VP
    J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of high affinity C5 convertase of the classical pathway of complement.
    Rawal N; Pangburn MK
    J Biol Chem; 2003 Oct; 278(40):38476-83. PubMed ID: 12878586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stringent regulation of complement lectin pathway C3/C5 convertase by C4b-binding protein (C4BP).
    Rawal N; Rajagopalan R; Salvi VP
    Mol Immunol; 2009 Sep; 46(15):2902-10. PubMed ID: 19660812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway.
    Takata Y; Kinoshita T; Kozono H; Takeda J; Tanaka E; Hong K; Inoue K
    J Exp Med; 1987 Jun; 165(6):1494-507. PubMed ID: 3495629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis for the Function of Complement Component C4 within the Classical and Lectin Pathways of Complement.
    Mortensen S; Kidmose RT; Petersen SV; Szilágyi Á; Prohászka Z; Andersen GR
    J Immunol; 2015 Jun; 194(11):5488-96. PubMed ID: 25911760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
    Kinoshita T; Dodds AW; Law SK; Inoue K
    Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    Kim YU; Carroll MC; Isenman DE; Nonaka M; Pramoonjago P; Takeda J; Inoue K; Kinoshita T
    J Biol Chem; 1992 Feb; 267(6):4171-6. PubMed ID: 1740458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
    J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between the binding sites of the complement regulatory proteins DAF, CR1, and factor H on C3 convertases.
    Pangburn MK
    J Immunol; 1986 Mar; 136(6):2216-21. PubMed ID: 2419425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
    Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure/function of C5 convertases of complement.
    Rawal N; Pangburn MK
    Int Immunopharmacol; 2001 Mar; 1(3):415-22. PubMed ID: 11367526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of activation of the alternative pathway of complement by cell-bound C4b.
    Farries TC; Steuer KL; Atkinson JP
    Mol Immunol; 1990 Nov; 27(11):1155-61. PubMed ID: 2247091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of complement C5 convertase enzymes.
    Pangburn MK; Rawal N
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1006-10. PubMed ID: 12440962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
    J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1.
    Avirutnan P; Fuchs A; Hauhart RE; Somnuke P; Youn S; Diamond MS; Atkinson JP
    J Exp Med; 2010 Apr; 207(4):793-806. PubMed ID: 20308361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of activation of the alternative complement pathway by the classical pathway: protection of C3b from inactivation by covalent attachment to C4b.
    Meri S; Pangburn MK
    Eur J Immunol; 1990 Dec; 20(12):2555-61. PubMed ID: 2148521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of action of decay-accelerating factor (DAF). DAF inhibits the assembly of C3 convertases by dissociating C2a and Bb.
    Fujita T; Inoue T; Ogawa K; Iida K; Tamura N
    J Exp Med; 1987 Nov; 166(5):1221-8. PubMed ID: 2445886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.